Monday 11 November 2013

Reduces the incidence of coronary

The ERT also reduces the incidence of coronary heart disease, prevents osteoporosis, improves cognitive function and macular degeneration and decreases the risk of colon cancer bowel.
However, Estrogen replacement therapy can have side effects such as vaginal bleeding and (breast pain), and potential risk of endometrial cancer and breast cancer. But the risk of hyperplasia or endometrial cancer is effectively counteracted by the association of estrogen with progesterone (Albright, 2000).for more information click here http://bosscraftlp.tk/groups/somanabolic-muscle-maximizer-the-fat-on-your-stomach-lose-it/
At per menopause, on average up to 4 years before the full stop menses, the patient usually seeks the doctor complaining of irregular bleeding.
The primary goal of therapy in these patients is the restoration of menstrual regularity. In these cases, the use of cyclic progestin’s is the most appropriate treatment.
Hormone Replacement Therapy (HRT) is the conventional administration of estrogens alone, and so indeed it is a Estrogen
Replacement Therapy (ERT). This TRE is only used in women hysterectomy (no uterus) or associated with progestins, when you want to protect the endometrial.click here http://miniclip.com.pk/groups/somanabolic-muscle-maximizer-lose-fat-one-more-reason-to-whey-protein-becomes-part-of-your-food-plan/
A Hormone Replacement Therapy (HRT) combined can be used cyclically or continuously. In a cyclical estrogen is administered continuously for 21 days or monthly, whereas progesterone is administered only during 10 to 14 days.

The suspension of progesterone normally cause menstrual bleeding, therefore, is a preferred scheme premenopausal or in early postmenopausal. On a continuous combined HRT patient to receive associated with daily estrogen and progestin, developing endometrial atrophy and therefore no monthly withdrawal bleeding. 

No comments:

Post a Comment